Descripción de negocio
Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.
Consejo de gestión & Consejo de supervisión
CEO |
Thomas Meier |
Consejo de gestión |
Alain Schaffter, Dr. Günther Loidl, Torsten Wohr |
Consejo de supervisión |
Dr. Kuno Sommer, Nicole Grogg Hötzer, Dr. Alex Fässler, Dr. Steffen Lang, Prof. Dr. Helma Wennemers, Dr. h.c. Peter Grogg |
Datos de la empresa
Nombre: |
Bachem Holding AG |
Dirección: |
Hauptstraße 144,CH-4416 Bubendorf |
Teléfono: |
+41-58-595-2020 |
Fax: |
+41-58-595-2040 |
E-mail: |
sales.ch@bachem.com
|
Internet: |
www.bachem.com |
Industria: |
Healthcare |
Sector: |
Pharmaceutical Industry |
Subsector: |
Pharmaceuticals |
Fin del año financiero: |
31/12 |
Acciones de libre circulación: |
38.00% |
Fecha de OPI: |
22/07/1998 |
Relación con inversores
Nombre: |
Daniel Grotzky |
IR teléfono: |
+41-58-595-2021 |
IR-fax: |
+41-58-595-2043 |
IR e-mail: |
ir@bachem.com
|